Blog

CO

Colorado info

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fco%2F"]

NE

Nebraska

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fne%2F"]

KA

Kansas info

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fka%2F"]

MA

Maryland info

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fma%2F"]

FL

florida info

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Ffl%2F"]

NY

Dr. Jonathan Jassey, DO, FAAP Concierge Pediatrics 1520 Old Northern Blvd, Rosyln, NY 11576 (516)514-7337 www.myconciergepediatrics.com   Dr. Sharon Semekh Concierge Pediatrics 1520 Old Northern Blvd, Rosyln, NY 11576 (516)514-7337 www.myconciergepediatrics.com

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fny%2F"]

IFU

https://cognoa-staging.com/wp-content/uploads/2023/06/CanvasDx_IndicationsforUse.pdf

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fwp-content%2Fuploads%2F2023%2F06%2FCanvasDx_IndicationsforUse.pdf%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Rise in autism prevalence highlights continued need for early intervention

https://www.contemporarypediatrics.com/view/rise-in-autism-prevalence-highlights-continued-need-for-early-intervention   Contemporary Pediatrics®: Hello and thank you for joining us. I’m Joshua Fitch, editor with Contemporary Pediatrics®. J. Thomas Megerian, MD, PhD, FAAP: Hi, I’m Tom Megerian, Joshua. I am Clinical Director at the Thompson Center for Autism and Neurodevelopmental Disorders at Children’s Health...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.contemporarypediatrics.com%2Fview%2Frise-in-autism-prevalence-highlights-continued-need-for-early-intervention%23new_tab"]

Autistic Woman Shares the 6 Surprising Signs Usually Ignored in Girls

https://www.newsweek.com/autistic-woman-shares-6-surprising-signs-usually-ignored-girls-1795838

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.newsweek.com%2Fautistic-woman-shares-6-surprising-signs-usually-ignored-girls-1795838%23new_tab"]

Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device

https://medcitynews.com/2023/02/health-transformation-alliance-teams-up-with-cognoa-for-autism-diagnostic-device/

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fmedcitynews.com%2F2023%2F02%2Fhealth-transformation-alliance-teams-up-with-cognoa-for-autism-diagnostic-device%2F%23new_tab"]

Cognoa and Health Transformation Alliance Partner to Provide Access to Child Health Solution Canvas Dx for Self-Insured Employers

https://www.prnewswire.com/il/news-releases/cognoa-and-health-transformation-alliance-partner-to-provide-access-to-child-health-solution-canvas-dx-for-self-insured-employers-301748831.html Nearly 60 of America’s leading employers will now be able to offer their employees with children access to Canvas Dx™, the first FDA-authorized diagnostic device for autism in young children – Health Transformation Alliance (HTA), a...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.prnewswire.com%2Fil%2Fnews-releases%2Fcognoa-and-health-transformation-alliance-partner-to-provide-access-to-child-health-solution-canvas-dx-for-self-insured-employers-301748831.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Shaping the future of early diagnosis with digital medicine – Dr. Sharief Taraman

https://ssistrategy.com/podcast/episode-9 As everyday consumers, we interact with AI (Artificial Intelligence) daily. Whether unlocking the home screen of our phones via facial recognition, using voice commands to send a text, or interacting with a chat tool when shopping online, AI adoption is continuous. But what...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fssistrategy.com%2Fpodcast%2Fepisode-9"]

Cognoa to Participate in BTIG Digital Health Forum 

https://www.prnewswire.com/il/news-releases/cognoa-to-participate-in-btig-digital-health-forum-301680076.html – Cognoa, a leading pediatric behavioral health company, today announced that Sharief Taraman, MD, DABPN, DABPM, FAAP, Chief Executive Officer of Cognoa, will participate in the opening analyst-led fireside chat at the BTIG Digital Health Forum...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.prnewswire.com%2Fil%2Fnews-releases%2Fcognoa-to-participate-in-btig-digital-health-forum-301680076.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa Appoints Pediatric Neurologist and AI in Healthcare Pioneer Dr. Sharief Taraman as CEO to Spearhead the Next Stage of the Company’s Growth

https://www.prnewswire.com/news-releases/cognoa-appoints-pediatric-neurologist-and-ai-in-healthcare-pioneer-dr-sharief-taraman-as-ceo-to-spearhead-the-next-stage-of-the-companys-growth-301677002.html Cognoa is on track for U.S. commercialization of Canvas Dx in 2023 as the first FDA authorized diagnostic device for early and equitable diagnosis of autism in young children – Cognoa, a pediatric behavioral health company,...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcognoa-appoints-pediatric-neurologist-and-ai-in-healthcare-pioneer-dr-sharief-taraman-as-ceo-to-spearhead-the-next-stage-of-the-companys-growth-301677002.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa Announces Poster Presentations at the 2022 American Academy of Pediatrics (AAP) National Conference and Exhibition

https://www.prnewswire.com/news-releases/cognoa-announces-poster-presentations-at-the-2022-american-academy-of-pediatrics-aap-national-conference-and-exhibition-301642639.html – Cognoa, a pediatric behavioral health company, today announced that the Company will be participating in the 2022 American Academy of Pediatrics (AAP) National Conference and Exhibition, taking place October 7 – 11, 2022, at the...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcognoa-announces-poster-presentations-at-the-2022-american-academy-of-pediatrics-aap-national-conference-and-exhibition-301642639.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Podcast: Diagnosing Autism Spectrum Disorder with DTx: Dennis Wall provides insights into Canvas Dx

https://digitalhealthtoday.com/episodes/digital-therapeutics-podcast/ep35-diagnosing-autism-spectrum-disorder-with-dtx-dennis-wall-provides-insights-into-canvas-dx/ Digital Health Today’s Podcast with Dennis Wall In this episode we jump back into interviewing some of the early trailblazers and speak with Dennis Wall, Founder of Cognoa. ->Listen Now<-   In their owns words, “Cognoa is a pediatric behavioral health company developing...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fdigitalhealthtoday.com%2Fepisodes%2Fdigital-therapeutics-podcast%2Fdiagnosing-autism-spectrum-disorder-with-dtx-dennis-wall-provides-insights-into-canvas-dx%2F"]

6 Things I’ve Learned From Children and Families Living with Autism by Colleen Kraft,MD, MBA, FAAP

https://cognoa-staging.com/wp-content/uploads/6_Things_Ive_Learned_From_Children_And_Families_Living_With_Autism-June2022.pdf

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fwp-content%2Fuploads%2F6_Things_Ive_Learned_From_Children_And_Families_Living_With_Autism-June2022.pdf%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

(PDF) 6 Things I’ve Learned From Children and Families Living with Autism by Colleen Kraft, MD, MBA, FAAP

6_Things_Ive_Learned_From_Children_And_Families_Living_With_Autism-June2022

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoaprodstg.wpengine.com%2Fwp-content%2Fuploads%2F2022%2F06%2F6_Things_Ive_Learned_From_Children_And_Families_Living_With_Autism-June2022.pdf%23new_tab"]

ECHO Autism Communities Collaborate with Cognoa to Study Real-World Application of Canvas Dx 

https://www.prnewswire.com/news-releases/echo-autism-communities-collaborate-with-cognoa-to-study-real-world-application-of-canvas-dx-301558915.html – Cognoa, a pediatric behavioral health company, is announcing the initiation of a real-world evidence study of its novel AI-based software as a medical device, Canvas Dx, in collaboration with the University of Missouri (MU) ECHO Autism...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fecho-autism-communities-collaborate-with-cognoa-to-study-real-world-application-of-canvas-dx-301558915.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa Announces Nature Digital Medicine Publication of Pivotal Study Results Showing the Effectiveness of its Digital Diagnostic Device for Autism

https://www.globenewswire.com/news-release/2018/08/27/1557135/0/en/Cognoa-Demonstrates-Advances-of-its-AI-Based-Technology-for-Identifying-Autism-in-Children.htmlPalo Alto, Calif, May 5, 2022 – Cognoa, a pediatric behavioral health company, today announced that npj Digital Medicine, a Nature Portfolio journal, has published data from its pivotal study of the company’s AI-based diagnosis aid for autism spectrum disorder (ASD), Canvas Dx™. Canvas...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2018%2F08%2F27%2F1557135%2F0%2Fen%2FCognoa-Demonstrates-Advances-of-its-AI-Based-Technology-for-Identifying-Autism-in-Children.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Why An Autism Diagnosis Is Not A Label But A Roadmap

https://www.forbes.com/sites/jenniferpalumbo/2022/04/25/why-an-autism-diagnosis-is-not-a-label-but-a-roadmap/?sh=570a3c4851ee

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.forbes.com%2Fsites%2Fjenniferpalumbo%2F2022%2F04%2F25%2Fwhy-an-autism-diagnosis-is-not-a-label-but-a-roadmap%2F%3Fsh%3D570a3c4851ee%26target%3D_blank%26rel%3Dnoopener%20noreferrer"]

Why An Autism Diagnosis Is Not A Label But A Roadmap

https://www.forbes.com/sites/jenniferpalumbo/2022/04/25/why-an-autism-diagnosis-is-not-a-label-but-a-roadmap/?sh=796f2b7a51ee

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.forbes.com%2Fsites%2Fjenniferpalumbo%2F2022%2F04%2F25%2Fwhy-an-autism-diagnosis-is-not-a-label-but-a-roadmap%2F%3Fsh%3D25c0952851ee%23new_tab"]

Cognoa to Present and Exhibit at the 2022 American Academy of Neurology (AAN) Annual Meeting

https://www.aan.com/events/2022-annual-meetingPalo Alto, Calif, April 4, 2022 – Cognoa, a pediatric behavioral health company, today announced it will be presenting and exhibiting at the 2022 American Academy of Neurology (AAN) Annual Meeting, which will be held April 2 – 7, 2022 in Seattle, Washington. The...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.aan.com%2Fevents%2F2022-annual-meeting%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Fierce Medtech’s 2021 Fierce 15

https://www.fiercebiotech.com/special-reports/fierce-medtechs-2021-fierce-15#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.fiercebiotech.com%2Fspecial-reports%2Ffierce-medtechs-2021-fierce-15%23new_tab"]

Cognoa Named One Of Fierce Medtech’s 2022 Fierce 15

https://www.fiercebiotech.com/medtech/fierce-medtechs-2022-fierce-15Palo Alto, CA – March 7, 2022 – Cognoa, a leading pediatric behavioral health company, today announced that it has been named by Fierce Medtech as one of 2021’s Fierce 15 med tech companies, designating it as one of the most promising private med...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Ffierce-medtechs-2022-fierce-15%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Healthcare Industry Still Lacks Inclusivity And Accessibility: These 7 Female Leaders Are Here To Change That

https://www.forbes.com/sites/marijabutkovic/2022/02/14/healthcare-industry-still-lacks-inclusivity-and-accessibility-these-7-female-leaders-are-here-to-change-that/?sh=2fa4c0b37a61#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.forbes.com%2Fsites%2Fmarijabutkovic%2F2022%2F02%2F14%2Fhealthcare-industry-still-lacks-inclusivity-and-accessibility-these-7-female-leaders-are-here-to-change-that%2F%3Fsh%3D49a836567a61%23new_tab"]

Facilitating Autism Diagnosis – Psychiatric Times

https://www.psychiatrictimes.com/view/facilitating-autism-diagnosis#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.psychiatrictimes.com%2Fview%2Ffacilitating-autism-diagnosis%23new_tab"]

AI, telehealth, and sensor-based technologies facilitate autism diagnosis

https://www.contemporarypediatrics.com/view/ai-telehealth-and-sensor-based-technologies-facilitate-autism-diagnosis#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.contemporarypediatrics.com%2Fview%2Fai-telehealth-and-sensor-based-technologies-facilitate-autism-diagnosis%23new_tab"]

Cognoa Appoints Seasoned Financial Executive, Tony Rimac, as Chief Financial Officer

Rimac joins Cognoa to provide financial and strategic leadership, bringing over 30 years of broad operating and finance experience within the pharmaceutical, medical device, biotechnology, and drug delivery industries

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.prnewswire.com%2Fil%2Fnews-releases%2Fcognoa-appoints-seasoned-financial-executive-tony-rimac-as-chief-financial-officer-301388897.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Is AI really that new to the healthcare sector?

https://www.youtube.com/watch?v=3ZF-kJSWqUE#new_tabHalim looks at how you can use data in the healthcare space.

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3D3ZF-kJSWqUE%23new_tab"]

Expert: AI/ML Pediatric Software Brings Hope – But Also Potential – To Magnifying Disparities

https://medtech.pharmaintelligence.informa.com/MT144425/Expert-AIML-Pediatric-Software-Brings-Hope–But-Also-Potential–To-Magnifying-Disparities#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fmedtech.pharmaintelligence.informa.com%2FMT144425%2FExpert-AIML-Pediatric-Software-Brings-Hope--But-Also-Potential--To-Magnifying-Disparities%23new_tab"]

AI-driven autism diagnosis aid receives FDA authorization

https://ai-med.io/real-life/ai-driven-autism-diagnosis-aid-receives-fda-authorization/#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fai-med.io%2Freal-life%2Fai-driven-autism-diagnosis-aid-receives-fda-authorization%2F%23new_tab"]

Sharief Taraman: using AI to fight disparities in medicine

https://medical-technology.nridigital.com/medical_technology_aug21/cognoa_ai_disparities_medicine

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fmedical-technology.nridigital.com%2Fmedical_technology_aug21%2Fcognoa_ai_disparities_medicine"]

Can AI Technology Help Tackle Disparities in Autism Diagnosis? Featured Image with Sidebar

https://www.autismparentingmagazine.com/ai-technology-disparities-diagnosis-autism/#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.autismparentingmagazine.com%2Fai-technology-disparities-diagnosis-autism%2F%23new_tab"]

Cognoa Receives FDA Marketing Authorization for First-of-its-kind Autism Diagnosis Aid

https://www.prnewswire.com/news-releases/cognoa-receives-fda-marketing-authorization-for-first-of-its-kind-autism-diagnosis-aid-301304351.htmlCognoa’s AI-driven device is the first FDA-authorized diagnosis aid designed to help primary care physicians diagnose autism in young children with the goal of shortening time-to-diagnosis and enabling initiation of earlier interventions (Palo Alto, Calif. – June 2nd, 2021) – Cognoa, a pediatric behavioral...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcognoa-receives-fda-marketing-authorization-for-first-of-its-kind-autism-diagnosis-aid-301304351.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Autism: Awareness, Acceptance, Action

By: Lani Hessen, Director of Advocacy, Cognoa, and Pediatric Occupational Therapist (OTR/L) Autism impacts an estimated 1 in 54 children in the U.S. today. Autism is a spectrum, representing a tremendous range of skills and challenges spanning learning and communication, socialization and developmental behaviors. ...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fautism-awareness-acceptance-action%2F"]

How Cognoa Aims to Revolutionize the Autism Diagnosis Process

https://bhbusiness.com/2021/04/06/how-cognoa-aims-to-revolutionize-the-autism-diagnosis-process/#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fbhbusiness.com%2F2021%2F04%2F06%2Fhow-cognoa-aims-to-revolutionize-the-autism-diagnosis-process%2F%23new_tab"]

Empowering Pediatricians to Diagnose Autism

https://apmagpdf.s3.amazonaws.com/Issue_118_Reframing_Education_In_The_New_Normal_5254.pdf#new_tab By David Happel This article was originally published in Autism Parenting Magazine, Issue 118. Nearly 80 years after psychiatrist Leo Kanner became the first physician to use the term “autism”, children and families with autism still face critical gaps and unnecessary delays on their way to...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fapmagpdf.s3.amazonaws.com%2FIssue_118_Reframing_Education_In_The_New_Normal_5254.pdf%23new_tab"]

Neuroscience: The next AI frontier

https://ai-med.io/special-report-neurosciences-mental-health/neuroscience-the-next-ai-frontier/#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fai-med.io%2Fspecial-report-neurosciences-mental-health%2Fneuroscience-the-next-ai-frontier%2F%23new_tab"]

Cognoa Appoints Industry Veteran Eric B. Mosbrooker as Chief Operations Officer

https://www.prnewswire.com/news-releases/cognoa-appoints-industry-veteran-eric-b-mosbrooker-as-chief-operations-officer-301208688.htmlMosbrooker will be leading the operational and commercial efforts of Cognoa’s digital behavioral health products (Palo Alto, Calif. – January 14, 2021) – Cognoa, the leading pediatric behavioral health company developing diagnostic and therapeutic solutions for children living with autism and other behavioral health...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcognoa-appoints-industry-veteran-eric-b-mosbrooker-as-chief-operations-officer-301208688.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Meet The Disruptors: David Happel of Cognoa On The Three Things You Need To Shake Up Your Industry

https://medium.com/authority-magazine/meet-the-disruptors-david-happel-of-cognoa-on-the-three-things-you-need-to-shake-up-your-industry-a7b69f0c172e#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fmedium.com%2Fauthority-magazine%2Fmeet-the-disruptors-david-happel-of-cognoa-on-the-three-things-you-need-to-shake-up-your-industry-a7b69f0c172e%23new_tab"]

From A Pediatrician: What To Do If You Think Your Child May Have ASD

https://www.scarymommy.com/what-to-do-suspect-child-autism#new_tab by Katie Cloyd  – December 18, 2020 So, you think your young child might be on the autism spectrum. Maybe they’re not talking or communicating as expected, or they don’t seem to understand when you talk to them. Perhaps they seem exceptionally frustrated and their tantrum...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.scarymommy.com%2Fwhat-to-do-suspect-child-autism%23new_tab"]

Startup Cognoa Seeks FDA Approval for Device with AI to Help Diagnose Autism

https://www.aitrends.com/healthcare/startup-cognoa-seeks-fda-approval-for-device-with-ai-to-help-diagnose-autism/#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.aitrends.com%2Fhealthcare%2Fstartup-cognoa-seeks-fda-approval-for-device-with-ai-to-help-diagnose-autism%2F%23new_tab"]

This AI Tool For Diagnosing Autism Could Hit The Market ‘In The Second Half Of 2021′

https://www.forbes.com/sites/graisondangor/2020/10/06/this-ai-tool-for-diagnosing-autism-could-hit-the-market-in-the-second-half-of-2021/?sh=5665ebde2038#new_tab

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.forbes.com%2Fsites%2Fgraisondangor%2F2020%2F10%2F06%2Fthis-ai-tool-for-diagnosing-autism-could-hit-the-market-in-the-second-half-of-2021%2F%3Fsh%3D62f78c3c2038%23new_tab"]

AI-powered app for diagnosing autism in children targets FDA clearance

https://www.nsmedicaldevices.com/news/diagnosing-autism-in-children-cognoa/##new_tab US firm Cognoa is targeting FDA approval for its AI-based smartphone app – which aims to improve the current approach to diagnosing autism in children By Jamie Bell   A new digital method for diagnosing autism in children may be set for FDA clearance...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.nsmedicaldevices.com%2Fnews%2Fdiagnosing-autism-in-children-cognoa%2F%23%23new_tab"]

Cognoa’s AI-powered diagnostic app for autism clears clinical study, heads for FDA review

https://www.fiercebiotech.com/medtech/cognoa-s-ai-powered-diagnostic-app-for-autism-clears-clinical-study-heads-for-fda-review#new_tab by Conor Hale Cognoa aims to equip primary care pediatricians with an artificial-intelligence-powered digital app that can spot the signs of autism, allowing them to rule out or diagnose spectrum disorders within the doctor’s office or remotely. This could represent a broad shift in...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Fcognoa-s-ai-powered-diagnostic-app-for-autism-clears-clinical-study-heads-for-fda-review%23new_tab"]

AI Tool to Diagnose Autism Could Give Concerned Parents a Fast Diagnosis

https://spectrum.ieee.org/cognoa-ai-autism-diagnostic-seeks-fda-clearance#new_tab The startup Cognoa has submitted its app-based tool for FDA clearance By Megan Scudellari This week, a California-based company announced it will seek FDA clearance for a first-of-its-kind autism spectrum disorder (ASD) diagnostic tool. Cognoa’s technology uses artificial intelligence to make an ASD diagnosis within weeks of signs...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fspectrum.ieee.org%2Fthe-human-os%2Fbiomedical%2Fdiagnostics%2Fcognoa-ai-autism-diagnostic-seeks-fda-clearance%23new_tab"]

Cognoa Seeks FDA Clearance for Breakthrough Digital Autism Diagnostic Device After Successful Pivotal Study

https://www.globenewswire.com/en/news-release/2020/09/23/2098045/0/en/Cognoa-Seeks-FDA-Clearance-for-Breakthrough-Digital-Autism-Diagnostic-Device-After-Successful-Pivotal-Study.htmlCognoa’s autism diagnostic device is positioned to be the first FDA-cleared digital solution enabling pediatricians to diagnose autism – a paradigm shift in the standard of care (Palo Alto, Calif. – September 23, 2020) – Cognoa, the leading pediatric behavioral health company developing diagnostic...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2020%2F09%2F23%2F2098045%2F0%2Fen%2FCognoa-Seeks-FDA-Clearance-for-Breakthrough-Digital-Autism-Diagnostic-Device-After-Successful-Pivotal-Study.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Shouldering the Mental Load on Your Own

https://www.parents.com/parenting/dynamics/single-parenting/shouldering-the-mental-load-on-your-own/ Single parents often carry the pressures of parenting on their own and burnout comes hard and fast. Relief does exist in the form of a support village—here’s what to know and how to create yours. By Adrienne Farr  Parenting is tough. Worrying about finances,...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.parents.com%2Fparenting%2Fdynamics%2Fsingle-parenting%2Fshouldering-the-mental-load-on-your-own%2F%23new_tab"]

When It Comes to Reopening, Your Kid Will Probably Fall Into One Of These 3 Categories

https://www.scarymommy.com/prepare-kids-transition-out-of-lockdown by Elaine Roth There was no preparation for the transition into lockdown. One day, COVID-19 was a vague virus I was reading about in the news, and the next, it was here—in my small town, in my schools. And everything shut down with alarming speed....

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.scarymommy.com%2Fprepare-kids-transition-out-of-lockdown%2F"]

How AI can overcome gender bias in autism diagnosis and treatment

https://medcitynews.com/2020/05/how-ai-can-overcome-gender-bias-in-autism-diagnosis-and-treatment/?rf=1#new_tab Researchers and advocates have convincingly shown that the wide gap in diagnoses between boys and girls isn’t simply a matter of boys being significantly more likely to be on the autism spectrum. By DAVID HAPPEL Statistically, boys are four times as likely as girls to receive...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fmedcitynews.com%2F2020%2F05%2Fhow-ai-can-overcome-gender-bias-in-autism-diagnosis-and-treatment%2F%3Frf%3D1%23new_tab"]

Home Together: Navigating COVID-19 and Disrupted Routines With Your ASD Child

https://www.autismparentingmagazine.com/coronavirus-and-autism/#new_tab Even as households worldwide self-isolate to help curb the spread of the novel coronavirus, we’re the furthest thing from isolated when it comes to what we’re experiencing—starting from the shared stress and concern we’re feeling amid such significant upheaval and uncertainty. For families with a...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.autismparentingmagazine.com%2Fcovid-19-autism-child-routines%2F%23new_tab"]

Cognoa Appoints Industry Leader David Happel as New Chief Executive Officer

https://www.globenewswire.com/en/news-release/2020/03/24/2005312/0/en/Cognoa-Appoints-Industry-Leader-David-Happel-as-New-Chief-Executive-Officer.htmlHappel takes up the top job at Cognoa after over 25 years of successfully commercializing medical products and as a leader in the biotech and biopharma industries.  (Palo Alto, Calif. – March 24, 2020) – Cognoa, the leading digital therapeutics company focused on pediatric...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2020%2F03%2F24%2F2005312%2F0%2Fen%2FCognoa-Appoints-Industry-Leader-David-Happel-as-New-Chief-Executive-Officer.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Can AI Help With Autism Diagnosis?

https://www.forbes.com/sites/cognitiveworld/2020/03/19/can-ai-help-with-autism-diagnosis/?sh=7a914cf764a3#42ed3bcc64a3#new_tab An Interview with Cognoa’s CEO Brent Vaughan In the US, one in five children are living with a diagnosable behavioral health disorder; however, only 21% of those children who are diagnosed receive needed treatment. Often, parents have to wait one to three years to receive a proper...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.forbes.com%2Fsites%2Fcognitiveworld%2F2020%2F03%2F19%2Fcan-ai-help-with-autism-diagnosis%2F%2342ed3bcc64a3%23new_tab"]

Multi-modular AI Approach to Streamline Autism Diagnosis in Young Children

Halim Abbas, Ford Garberson, Stuart Liu-Mayo, Eric Glover & Dennis P. Wall  Scientific Reports volume 10, Article number: 5014 (2020) Cite this article 2 Altmetric | Metricsdetails Abstract Autism has become a pressing healthcare challenge. The instruments used to aid diagnosis are time and labor expensive and require trained clinicians to administer, leading to long wait...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fmulti-modular-ai-approach-to-streamline-autism-diagnosis-in-young-children%2F"]

How AI Can Transform the Autism Services Industry

https://www.forbes.com/sites/forbesbooksauthors/2020/03/12/how-ai-can-transform-the-autism-services-industry/?sh=778224d867ac#24e4cf8567ac#new_tab Ronit Molko, Ph.D., BCBA-D describes how AI will become the norm of autism services, as it has in other industries, including Cognoa’s digital therapeutics that create a more proactive role for parents and pediatricians in the diagnostic and treatment processes to accomplish early...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.forbes.com%2Fsites%2Fforbesbooksauthors%2F2020%2F03%2F12%2Fhow-ai-can-transform-the-autism-services-industry%2F%2324e4cf8567ac%23new_tab"]

Cognoa Appoints Dr. Colleen Kraft Senior Medical Director of Clinical Adoption

https://www.globenewswire.com/en/news-release/2020/03/05/1995917/0/en/Cognoa-Appoints-Dr-Colleen-Kraft-Senior-Medical-Director-of-Clinical-Adoption.htmlAAP 2018 Past President Joins Cognoa to Improve the Standard of Care for Children with Autism Through Greater Pediatrician Adoption of Digital Prescription Apps (Palo Alto, Calif.– March 5, 2020) – Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2020%2F03%2F05%2F1995917%2F0%2Fen%2FCognoa-Appoints-Dr-Colleen-Kraft-Senior-Medical-Director-of-Clinical-Adoption.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa CEO to Participate in the Cowen and Company 40th Annual Healthcare Conference

https://www.globenewswire.com/en/news-release/2020/02/26/1991052/0/en/Cognoa-CEO-to-Participate-in-the-Cowen-and-Company-40th-Annual-Healthcare-Conference.htmlPALO ALTO, Calif. — February 26, 2020 — Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that CEO, Brent Vaughan, will participate in a digital therapeutics panel discussion at the Cowen and Company 40th Annual Healthcare Conference with executives...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2020%2F02%2F26%2F1991052%2F0%2Fen%2FCognoa-CEO-to-Participate-in-the-Cowen-and-Company-40th-Annual-Healthcare-Conference.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa teams up with Autism Learning Partners to distribute its smartphone screening app

https://www.fiercebiotech.com/medtech/cognoa-teams-up-autism-learning-partners-to-distribute-its-smartphone-screening-app#new_tab Pediatric digital therapeutics developer Cognoa has teamed up with Autism Learning Partners, a specialized treatment provider, to put its autism screening app in the hands of parents to help track their children’s development. Read the full article here.

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Fcognoa-teams-up-autism-learning-partners-to-distribute-its-smartphone-screening-app%23new_tab"]

Autism Learning Partners and Cognoa Announce Partnership to Enable Earlier Access to Care

https://www.globenewswire.com/en/news-release/2020/02/11/1983107/0/en/Autism-Learning-Partners-and-Cognoa-Announce-Partnership-to-Enable-Earlier-Access-to-Care.htmlPASADENA and PALO ALTO, Calif. – February 11, 2020 –  Autism Learning Partners (“ALP”), a national leader in the treatment of autism and other developmental disabilities, and Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today a partnership designed to...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2020%2F02%2F11%2F1983107%2F0%2Fen%2FAutism-Learning-Partners-and-Cognoa-Announce-Partnership-to-Enable-Earlier-Access-to-Care.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa Executives to Speak at DTx West 2020

https://www.globenewswire.com/en/news-release/2020/02/10/1982378/0/en/Cognoa-Executives-to-Speak-at-DTx-West-2020.htmlPALO ALTO, Calif. — February 10, 2020 — Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that three company executives will be on stage at the third annual DTx West 2020, taking place in San Mateo, California, February 18...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2020%2F02%2F10%2F1982378%2F0%2Fen%2FCognoa-Executives-to-Speak-at-DTx-West-2020.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa Named to the 2020 Global Digital Health 100 By The Journal of mHealth

https://www.globenewswire.com/en/news-release/2020/01/29/1976820/0/en/Cognoa-Named-to-the-2020-Global-Digital-Health-100-By-The-Journal-of-mHealth.htmlInternational Health Technology Publication Annual List Recognizes Innovation and Leaders in Health Technology Palo Alto, Calif., and London – January 29, 2020 –  Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, has been named to the 2020 Global Digital Health 100...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2020%2F01%2F29%2F1976820%2F0%2Fen%2FCognoa-Named-to-the-2020-Global-Digital-Health-100-By-The-Journal-of-mHealth.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Digital therapeutics can solve the greatest unmet need in behavioral healthcare: early intervention

https://medcitynews.com/2020/01/digital-therapeutics-can-solve-the-greatest-unmet-need-in-behavioral-healthcare-early-intervention/?rf=1#new_tab Cognoa CMO, Sharief Taraman, MD, DABPN, DABPM, FAAP, authored a MedCity News Influencer article about the potential of digital therapeutics and ai to empower pediatricians and make early intervention possible for more children. Our mental and behavioral health is largely determined by how...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fmedcitynews.com%2F2020%2F01%2Fdigital-therapeutics-can-solve-the-greatest-unmet-need-in-behavioral-healthcare-early-intervention%2F%3Frf%3D1%23new_tab"]

Cognoa CEO and CMO Presenting at Digital Medicine & Medtech Showcase 2020 and Innovator MD Global Summit in San Francisco

https://www.globenewswire.com/en/news-release/2020/01/06/1966474/0/en/Cognoa-CEO-and-CMO-Presenting-at-Digital-Medicine-Medtech-Showcase-2020-and-InnovatorMD-Global-Summit-in-San-Francisco.htmlPALO ALTO, Calif.- January 6, 2020—Cognoa, the leading digital therapeutics company focused on pediatric behavioral health, announced today that senior executives will be speaking at two healthcare innovation and investor conferences in San Francisco. ● Brent Vaughan, CEO and co-founder of Cognoa, will provide...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2020%2F01%2F06%2F1966474%2F0%2Fen%2FCognoa-CEO-and-CMO-Presenting-at-Digital-Medicine-Medtech-Showcase-2020-and-InnovatorMD-Global-Summit-in-San-Francisco.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa Wins 2019 Fierce Innovation Life Science Award

https://www.globenewswire.com/en/news-release/2019/12/18/1962445/0/en/Cognoa-Wins-2019-Fierce-Innovation-Life-Science-Award.html Palo Alto, Calif., December 18, 2019 –  Cognoa, a company at the forefront of pediatric behavioral health, has won the Fierce Innovation Life Science Award for Technology Innovation. Cognoa’s digital therapeutics will advance the standard of care by giving every child the opportunity...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2019%2F12%2F18%2F1962445%2F0%2Fen%2FCognoa-Wins-2019-Fierce-Innovation-Life-Science-Award.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Newly Expanded Recommendations on Autism Seek to Catch More Kids Who Might Fall Through the Cracks

https://elemental.medium.com/newly-expanded-recommendations-on-autism-seek-to-catch-more-kids-who-might-fall-through-the-cracks-5a7e1db50c7a#new_tab WRITTEN BY Shannon Ashley The American Academy of Pediatrics (AAP) recommends that all children get screened for autism spectrum disorder at their 18- and 24-month well-child checkups. Today, those recommendations have been significantly enhanced. These new guidelines now recommend developmental and behavioral surveillance at 9-,...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fmedium.com%2F%40Shesreallyfat%2Fnewly-expanded-recommendations-on-autism-seek-to-catch-more-kids-who-might-fall-through-the-cracks-5a7e1db50c7a%23new_tab"]

Cognoa Selected as Finalist in Fierce Innovation Awards – LifeSciences Edition 2019

https://www.bloomberg.com/press-releases/2019-12-05/cognoa-selected-as-finalist-in-fierce-innovation-awards-life-sciences-edition-2019Cognoa develops AI-powered digital therapeutics and medicines that advance the standard of care in pediatric behavioral health and improve lifelong outcomes for children Palo Alto, Calif., December 5, 2019 –  Cognoa, a company at the forefront of pediatric behavioral health, announced today that it...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.bloomberg.com%2Fpress-releases%2F2019-12-05%2Fcognoa-selected-as-finalist-in-fierce-innovation-awards-life-sciences-edition-2019%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

ASD symptoms in toddlers and preschoolers: An examination of sex differences

Rosmary Ros‐Demarize, Catherine Bradley, Stephen M. Kanne, Zachary Warren, Andrea Boan, Clara Lajonchere, Justine Park, Laura Arnstein Carpenter Abstract Although considerable work has documented higher prevalence rates of autism spectrum disorder (ASD) in boys, fewer studies have focused on sex differences within samples of young children...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fasd-symptoms-in-toddlers-and-preschoolers-an-examination-of-sex-differences%2F"]

Cognoa to Participate in BTIG DIGITAL HEALTH and EVERCORE ISI HealthCONx Conferences.

https://www.globenewswire.com/news-release/2019/11/14/1947500/0/en/COGNOA-TO-PARTICIPATE-IN-BTIG-DIGITAL-HEALTH-AND-EVERCORE-ISI-HealthCONx-CONFERENCES.htmlPalo Alto, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking at two upcoming investor conferences: BTIG Digital Health 2019: Industry Innovators on What’s Next. Panel entitled, “Developing Commercial...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fcognoa-to-participate-in-btig-digital-health-and-evercore-isi-healthconx-conferences%2F"]

Digital Therapeutics in Pediatric Behavioral Health — A unique opportunity to improve the standard of care and lifelong outcomes.

By Brent Vaughan, CEO and Co-Founder, Cognoa. We are experiencing a mental health crisis:one person in every four in the world will develop one or more behavioral conditions during their lifetime. Today in the U.S., one in five children have a diagnosable behavioral health disorder...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fdigital-therapeutics-in-pediatric-behavioral-health-a-unique-opportunity-to-improve-the-standard-of-care-and-lifelong-outcomes%2F"]

Cognoa CEO Brent Vaughan to Speak at HLTH and CNS Summit.

https://www.globenewswire.com/news-release/2019/10/28/1936418/0/en/Cognoa-CEO-Brent-Vaughan-to-Speak-at-HLTH-and-CNS-Summit.htmlPalo Alto, Calif. and Orlando, Oct. 28, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today that CEO Brent Vaughan will be speaking about the future of digital therapeutics at two conferences this week, HLTH and CNS Summit....

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2019%2F10%2F28%2F1936418%2F0%2Fen%2FCognoa-CEO-Brent-Vaughan-to-Speak-at-HLTH-and-CNS-Summit.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa Launches Pivotal Study of the First Digital Diagnostic for Autism.

https://www.globenewswire.com/news-release/2019/10/24/1935017/0/en/Cognoa-Launches-Pivotal-Study-of-the-First-Digital-Diagnostic-for-Autism.htmlPalo Alto, Calif., Oct. 24, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of pediatric behavioral health, announced today initiation of its Pivotal Study to demonstrate the effectiveness of its diagnostic aid for autism spectrum disorder (ASD). The company anticipates submitting the results...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2019%2F10%2F24%2F1935017%2F0%2Fen%2FCognoa-Launches-Pivotal-Study-of-the-First-Digital-Diagnostic-for-Autism.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

What are the challenges and opportunities of running clinical trials of digital therapeutics?

https://medcitynews.com/2019/09/presentation-highlights-challenges-and-opportunities-in-digital-therapeutics-clinical-trials/?rf=1https://medcitynews.com/2019/09/presentation-highlights-challenges-and-opportunities-in-digital-therapeutics-clinical-trials/?rf=1#new_tab Digital therapeutics clinical trials enable collection and analysis of data in real time, but considerations like standardization of analysis, trial endpoints and placebo controls are critical, experts at the DTx East conference in Boston said. Read full article here.

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fmedcitynews.com%2F2019%2F09%2Fpresentation-highlights-challenges-and-opportunities-in-digital-therapeutics-clinical-trials%2F%3Frf%3D1https%3A%2F%2Fmedcitynews.com%2F2019%2F09%2Fpresentation-highlights-challenges-and-opportunities-in-digital-therapeutics-clinical-trials%2F%3Frf%3D1%23new_tab"]

Cognoa and EVERSANA™ announce partnership to advance the commercialization standard for prescription digital medicines.

https://www.eversana.com/ja/2019/09/10/cognoa-and-eversana-announce-partnership-to-advance-the-commercialization-standard-for-prescription-digital-medicines/PALO ALTO, Calif. and CHICAGO, Sept. 10, 2019 /PRNewswire/ — Cognoa, a company at the forefront of pediatric behavioral health, and EVERSANA™, the leading independent provider of global commercial services to the life science industry, today announced a partnership to advance the industry standard by which digital medicines will be...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.eversana.com%2Fja%2F2019%2F09%2F10%2Fcognoa-and-eversana-announce-partnership-to-advance-the-commercialization-standard-for-prescription-digital-medicines%2F%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

In-Home Speech and Language Screening for Young Children: A Proof-of-Concept Study Using Interactive Mobile Storytime

Du Y1,2, Abbas H2, Taraman S1,2,3, Segar S2, Bischoff N2. Author information 1University of California, Irvine, CA, USA.2Cognoa Inc., Palo Alto, CA, USA.3Children’s Hospital of Orange County, Orange, CA, USA. Abstract Early identification and intervention of speech and language delays in children contribute to better communication and literacy...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fin-home-speech-and-language-screening-for-young-children-a-proof-of-concept-study-using-interactive-mobile-storytime%2F"]

Cognoa Licenses Innovative Digital Therapeutic Technology.

https://www.globenewswire.com/en/news-release/2019/04/10/1802043/0/en/Cognoa-Licenses-Innovative-Digital-Therapeutic-Technology.htmlPALO ALTO, Calif., April 10, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of digital behavioral health for children, today announces it has exclusively licensed technology from the Stanford University School of Medicine to accelerate development and worldwide commercialization of a novel digital...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fen%2Fnews-release%2F2019%2F04%2F10%2F1802043%2F0%2Fen%2FCognoa-Licenses-Innovative-Digital-Therapeutic-Technology.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

When Are We Sure? Predictors of Clinician Certainty in the Diagnosis of Autism Spectrum Disorder.

Journal of Autism and Developmental Disorders. Abstract Differential diagnosis of autism spectrum disorder (ASD) is challenging, and uncertainty regarding a child’s diagnosis may result in under-identification or prolonged diagnostic pathways. The current study examined diagnostic certainty, or how sure clinicians were that their diagnosis...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fwhen-are-we-sure-predictors-of-clinician-certainty-in-the-diagnosis-of-autism-spectrum-disorder%2F"]

Effect of Wearable Digital Intervention for Improving Socialization in Children With Autism Spectrum Disorder: A Randomized Clinical Trial

JAMA Pediatr. 2019;173(5):446-454. doi:10.1001/jamapediatrics.2019.0285 Catalin Voss, MS1; Jessey Schwartz, BA2; Jena Daniels, BS2; et al Abstract Importance  Autism behavioral therapy is effective but expensive and difficult to access. While mobile technology–based therapy can alleviate wait-lists and scale for increasing demand, few clinical trials exist to support its use for autism spectrum disorder (ASD) care. Objective  To...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Feffect-of-wearable-digital-intervention-for-improving-socialization-in-children-with-autism-spectrum-disorder-a-randomized-clinical-trial%2F"]

Cognoa Receives FDA Breakthrough Designations for Autism Diagnostic and Digital Therapeutic Devices.

https://www.globenewswire.com/news-release/2019/02/06/1711471/0/en/Cognoa-Receives-FDA-Breakthrough-Designations-for-Autism-Diagnostic-and-Digital-Therapeutic-Devices.htmlPALO ALTO, Calif., Feb. 06, 2019 (GLOBE NEWSWIRE) — Cognoa, a company at the forefront of digital behavioral health for children, today announces it has received Breakthrough Device designations from the U.S. Food and Drug Administration (FDA) for its lead products, the first digital diagnostic...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2019%2F02%2F06%2F1711471%2F0%2Fen%2FCognoa-Receives-FDA-Breakthrough-Designations-for-Autism-Diagnostic-and-Digital-Therapeutic-Devices.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Cognoa Selected by Cambia Health Solutions to Provide Support for Employees Raising Young Children.

https://www.globenewswire.com/news-release/2019/01/08/1682126/0/en/Cognoa-Selected-by-Cambia-Health-Solutions-to-Provide-Support-for-Employees-Raising-Young-Children.html Email Print Friendly ShareJanuary 08, 2019 09:03 ET | Source: Cognoa PALO ALTO, Calif., Jan. 08, 2019 (GLOBE NEWSWIRE) — Cognoa, a digital behavioral health company, announced today that Cambia Health Solutions, Inc. (Cambia) is incorporating Cognoa’s evidence-based platform within its subsidiary health plans. Cognoa provides support for employees caring...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2019%2F01%2F08%2F1682126%2F0%2Fen%2FCognoa-Selected-by-Cambia-Health-Solutions-to-Provide-Support-for-Employees-Raising-Young-Children.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Mobile detection of autism through machine learning on home video: A development and prospective validation study.

Plos Medicine. Published: November 27, 2018. Abstract Background The standard approaches to diagnosing autism spectrum disorder (ASD) evaluate between 20 and 100 behaviors and take several hours to complete. This has in part contributed to long wait times for a diagnosis and subsequent delays...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fmobile-detection-of-autism-through-machine-learning-on-home-video-a-development-and-prospective-validation-study%2F"]

Cognoa Demonstrates Advances of its AI-Based Technology for Identifying Autism in Children

https://www.globenewswire.com/news-release/2018/08/27/1557135/0/en/Cognoa-Demonstrates-Advances-of-its-AI-Based-Technology-for-Identifying-Autism-in-Children.htmlPALO ALTO, Calif., Aug. 27, 2018 (GLOBE NEWSWIRE) — Cognoa, a digital behavioral health company, today announces results from a clinical study of its second-generation AI based algorithms which demonstrates accuracy improvements over its first-generation screening algorithm in supporting the diagnosis of autism spectrum...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2018%2F08%2F27%2F1557135%2F0%2Fen%2FCognoa-Demonstrates-Advances-of-its-AI-Based-Technology-for-Identifying-Autism-in-Children.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Exploratory study examining the at-home feasibility of a wearable tool for social-affective learning in children with autism.

npj Digital Medicine. Published: 02 August 2018. Abstract Although standard behavioral interventions for autism spectrum disorder (ASD) are effective therapies for social deficits, they face criticism for being time-intensive and overdependent on specialists. Earlier starting age of therapy is a strong predictor of later success,...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fexploratory-study-examining-the-at-home-feasibility-of-a-wearable-tool-for-social-affective-learning-in-children-with-autism%2F"]

SAP Teams with Cognoa to Bridge Gap in Healthcare for Employees Raising Young Children.

https://www.globenewswire.com/news-release/2018/06/12/1520417/0/en/SAP-Teams-with-Cognoa-to-Bridge-Gap-in-Healthcare-for-Employees-Raising-Young-Children.htmlPALO ALTO, Calif., June 12, 2018 (GLOBE NEWSWIRE) — Cognoa, a digital behavioral health company, today announces its partnership with SAP, a market leader in enterprise application software. More than 19,000 SAP employees in North America will now have access to Cognoa’s app to help their...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2018%2F06%2F12%2F1520417%2F0%2Fen%2FSAP-Teams-with-Cognoa-to-Bridge-Gap-in-Healthcare-for-Employees-Raising-Young-Children.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Screening in toddlers and preschoolers at risk for autism spectrum disorder: Evaluating a novel mobile‐health screening tool.

Wiley Online Library. Abstract There are many available tools with varying levels of accuracy designed to screen for Autism Spectrum Disorder (ASD) in young children, both in the general population and specifically among those referred for developmental concerns. With burgeoning waitlists for comprehensive diagnostic...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fscreening-in-toddlers-and-preschoolers-at-risk-for-autism-spectrum-disorder-evaluating-a-novel-mobile%25e2%2580%2590health-screening-tool%2F"]

Machine learning approach for early detection of autism by combining questionnaire and home video screening.

JAMIA. Abstract Background Existing screening tools for early detection of autism are expensive, cumbersome, time- intensive, and sometimes fall short in predictive value. In this work, we sought to apply Machine Learning (ML) to gold standard clinical data obtained across thousands of children at-risk...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fmachine-learning-approach-for-early-detection-of-autism-by-combining-questionnaire-and-home-video-screening%2F"]

Cognoa Hits Major Milestone Towards First AI-Based Autism Diagnostic.

https://www.globenewswire.com/news-release/2018/02/21/1372689/0/en/Cognoa-Hits-Major-Milestone-Towards-First-AI-Based-Autism-Diagnostic.html/PALO ALTO, Calif., Feb. 21, 2018 (GLOBE NEWSWIRE) — Cognoa, a company offering an AI-based platform for pediatric behavioral health diagnostics and digital therapeutics, announces that the U.S. Food and Drug Administration (FDA) has established that Cognoa’s software is a Class II diagnostic medical...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.globenewswire.com%2Fnews-release%2F2018%2F02%2F21%2F1372689%2F0%2Fen%2FCognoa-Hits-Major-Milestone-Towards-First-AI-Based-Autism-Diagnostic.html%2F%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Sparsifying machine learning models identify stable subsets of predictive features for behavioral detection of autism.

Molecular Autism. Abstract Background Autism spectrum disorder (ASD) diagnosis can be delayed due in part to the time required for administration of standard exams, such as the Autism Diagnostic Observation Schedule (ADOS). Shorter and potentially mobilized approaches would help to alleviate bottlenecks in the...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fsparsifying-machine-learning-models-identify-stable-subsets-of-predictive-features-for-behavioral-detection-of-autism%2F"]

Machine learning for early detection of autism (and other conditions) using a parental questionnaire and home video screening.

2017 IEEE International Conference on Big Data. Abstract Existing screening tools for early detection of autism are expensive, cumbersome, time-intensive, and sometimes fall short in predictive value. In this work, we apply Machine Learning to gold standard clinical data obtained across thousands of children...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fmachine-learning-for-early-detection-of-autism-and-other-conditions-using-a-parental-questionnaire-and-home-video-screening%2F"]

Cognoa Hires Vice President of Medical, Further Advancing Developmental Diagnosis Technology.

https://www.prnewswire.com/news-releases/cognoa-announces-leadership-expansion-with-strategic-hires-301840253.htmlPALO ALTO, CA–(Marketwired – Jun 14, 2017) – Cognoa, a digital health company revolutionizing how children with developmental delays are diagnosed and supported, today announces Sharief Taraman, MD as its vice president of medical and clinical. Dr. Taraman will lead the company’s further clinical validation...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fwww.prnewswire.com%2Fnews-releases%2Fcognoa-announces-leadership-expansion-with-strategic-hires-301840253.html%3Ftarget%3D_blank%26rel%3Dnoopener%20noreferrer"]

Crowdsourced validation of a machine-learning classification system for autism and ADHD.

Translational Psychiatry. Abstract Autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) together affect >10% of the children in the United States, but considerable behavioral overlaps between the two disorders can often complicate differential diagnosis. Currently, there is no screening test designed to...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fcrowdsourced-validation-of-a-machine-learning-classification-system-for-autism-and-adhd%2F"]

Clinical Evaluation of a Novel and Mobile Autism Risk Assessment.

Journal of Autism and Developmental Disorders. Abstract The Mobile Autism Risk Assessment (MARA) is a new, electronically administered, 7-question autism spectrum disorder (ASD) screen to triage those at highest risk for ASD. Children 16 months–17 years (N = 222) were screened during their first visit in a developmental-behavioral...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fclinical-evaluation-of-a-novel-and-mobile-autism-risk-assessment%2F"]

A Wearable Social Interaction Aid for Children with Autism.

In Proceedings of the 2016 CHI Conference Extended Abstracts on Human Factors in Computing Systems. Abstract Over 1 million children under the age of 17 in the US have been identified with Autism Spectrum Disorder (ASD). These children struggle to recognize facial expressions, make...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fa-wearable-social-interaction-aid-for-children-with-autism%2F"]

Use of machine learning for behavioral distinction of autism and ADHD

Translational Psychiatry volume 6, page 732(2016) M Duda, R Ma, N Haber & D P Wall Abstract Although autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) continue to rise in prevalence, together affecting >10% of today’s pediatric population, the methods of diagnosis remain subjective, cumbersome and time intensive. With...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fuse-of-machine-learning-for-behavioral-distinction-of-autism-and-adhd%2F"]

Searching for a minimal set of behaviors for autism detection through feature selection-based machine learning.

Translational Psychiatry. Abstract Although the prevalence of autism spectrum disorder (ASD) has risen sharply in the last few years reaching 1 in 68, the average age of diagnosis in the United States remains close to 4—well past the developmental window when early intervention has...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fsearching-for-a-minimal-set-of-behaviors-for-autism-detection-through-feature-selection-based-machine-learning%2F"]

Use of Artificial Intelligence to Shorten the Behavioral Diagnosis of Autism.

PLOS ONE. Abstract The Autism Diagnostic Interview-Revised (ADI-R) is one of the most commonly used instruments for assisting in the behavioral diagnosis of autism. The exam consists of 93 questions that must be answered by a care provider within a focused session that often...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fuse-of-artificial-intelligence-to-shorten-the-behavioral-diagnosis-of-autism%2F"]

Use of machine learning to shorten observation-based screening and diagnosis of autism.

Translational Psychiatry. Abstract The Autism Diagnostic Observation Schedule-Generic (ADOS) is one of the most widely used instruments for behavioral evaluation of autism spectrum disorders. It is composed of four modules, each tailored for a specific group of individuals based on their language and developmental...

[dt_sc_button title="Read More" style="filled" icon_type="fontawesome" iconalign="icon-right with-icon" iconclass="fa fa-long-arrow-right" class="type1" link="url:https%3A%2F%2Fcognoa-staging.com%2Fuse-of-machine-learning-to-shorten-observation-based-screening-and-diagnosis-of-autism%2F"]